Literature DB >> 7567475

Synthesis of 3H-labeled nucleoside-methyl[CT3]phosphonamidite and incorporation into methylphosphonate oligonucleotides for biodistribution and biostability studies.

M M Vaghefi1, R C Fazio, K M Young, W B Marvin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7567475      PMCID： PMC307243          DOI： 10.1093/nar/23.17.3600

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  10 in total

1.  Antisense oligonucleotides: inhibition of liver cell proliferation and in vivo disposition.

Authors:  M Inagaki; K Togawa; B I Carr; K Ghosh; J S Cohen
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice.

Authors:  G Goodarzi; M Watabe; K Watabe
Journal:  Biopharm Drug Dispos       Date:  1992-04       Impact factor: 1.627

3.  Disposition and metabolism of oligodeoxynucleoside methylphosphonate following a single i.v. injection in mice.

Authors:  T L Chen; P S Miller; P O Ts'o; O M Colvin; T L Chem
Journal:  Drug Metab Dispos       Date:  1990 Sep-Oct       Impact factor: 3.922

Review 4.  Current concepts in antisense drug design.

Authors:  J F Milligan; M D Matteucci; J C Martin
Journal:  J Med Chem       Date:  1993-07-09       Impact factor: 7.446

Review 5.  Development of antisense therapeutics. Implications for cancer gene therapy.

Authors:  J F Milligan; R J Jones; B C Froehler; M D Matteucci
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

6.  Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.

Authors:  H Sands; L J Gorey-Feret; A J Cocuzza; F W Hobbs; D Chidester; G L Trainor
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

7.  Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.

Authors:  S Agrawal; J Temsamani; J Y Tang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

Review 8.  Applications of antisense oligonucleotides in oncology.

Authors:  J Y Pierga; H Magdelenat
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1994-05       Impact factor: 1.770

9.  An improved method for the synthesis and deprotection of methylphosphonate oligonucleotides.

Authors:  R I Hogrefe; M A Reynolds; M M Vaghefi; K M Young; T A Riley; R E Klem; L J Arnold
Journal:  Methods Mol Biol       Date:  1993

10.  Deprotection of methylphosphonate oligonucleotides using a novel one-pot procedure.

Authors:  R I Hogrefe; M M Vaghefi; M A Reynolds; K M Young; L J Arnold
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971
  10 in total
  1 in total

1.  Synthesis and thermodynamics of oligonucleotides containing chirally pure R(P) methylphosphonate linkages.

Authors:  M A Reynolds; R I Hogrefe; J A Jaeger; D A Schwartz; T A Riley; W B Marvin; W J Daily; M M Vaghefi; T A Beck; S K Knowles; R E Klem; L J Arnold
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.